Pentobarbital Dose Too Small to Kill: Pike Survives Tennessee Injection

Christa Pike survived a lethal injection on 30 September after receiving only a fraction of the intended dose of pentobarbital. Legal filings released on 24 October reveal that the administration team in Tennessee struggled for nearly an hour to insert an intravenous line. The procedure was halted before the full 5 grams of the drug could be delivered, leaving Pike in a hospital bed rather than a grave.

Pike, who was sentenced to death for the 1995 murder of Colleen Slemmer, entered the death chamber with a history of difficult veins. Her attorney, Randy Spivey, documented the events of the attempt. He stated that four unidentified team members used approximately 10 needles to try to secure a line in her arms. The team reportedly feared at multiple points that the veins had "blown." Pike grimaced and stated her arm was "really burning," a reaction that standard labels on the pentobarbital vial indicate should stop the infusion immediately.

The timeline provided in court shows the team escalating their efforts as time passed. At 7:05 pm, about 30 minutes into the process, a member requested a 24-gauge needle. Joel Zivot, a professor of anesthesiology who provided expert testimony before the execution, identified this as a catheter size typically used for infants. He argued that pushing a 50cc syringe through such a small tube would inevitably damage the vein. By 7:07 pm, a team member acknowledged the failure, stating, "I think it is blown."

The team then attempted to use ultrasound to locate a viable vein. Jonathan Groner, an emeritus professor of clinical surgery at Ohio State University, noted that this technique requires extensive specialist training. He observed that the team appeared unfamiliar with the equipment. At 7:23 pm, saline was pushed through the line with difficulty. One minute later, at 7:24 pm, the team declared the IV ready and began the injection. Groner described this as a flashing red light that no clinician would ignore.

Pike's legal team had warned the state multiple times prior to the attempt that her veins were exceptionally small. Zivot cited several specific failures, including a poorly written protocol and the use of technology the team may not have been authorized to operate. He stated that the team pressed forward when they should have stopped. He emphasized that medicine relies on safety and training, neither of which were visible in the execution chamber.

Following the failed injection, Pike spent ten days in a hospital, including several days on a ventilator. Her lawyers initially assumed she had suffered brain death. She has since returned to her prison cell and can now talk and walk. Her long-term medical prognosis remains unknown.

Tennessee has suspended all executions pending a review of its protocols. The case has drawn attention from medical professionals who argue the event exposes systemic issues in the use of lethal injection. Groner described the process as a "medical charade" and stated that the ultimate penalty is death, not torture followed by death. The state is now under scrutiny to determine how a procedure designed to end a life resulted in a survivor.

The legal proceedings continue as the court evaluates the expert testimony and the timeline provided by Spivey. The next phase will determine whether the state attempts a new execution or seeks a different method of carrying out the sentence. The outcome will set a precedent for other states relying on similar protocols.